Sayed Criticizes Rogers for Skipping Michigan Senate Debate, Calls Absence a Missed Moment for Voters
Abdul-El Sayed reproaches Mike Rogers for not attending a scheduled Michigan Senate debate, framing the absence as avoidance ahead of the vote.
Events
Read Full News
News Helicopter Crashes into Flames Near LA Bus Collision, At Least Three Dead
A news helicopter crashed and burst into flames near a bus collision in Los Angeles, killing at least three people. Authorities have released few details.
Wolff urges caution as Antonelli’s lead grows, warns of ‘black swan’ risks
Mercedes boss Toto Wolff cautions Kimi Antonelli to stay vigilant despite his commanding points lead, highlighting unpredictable risks to the title fight.
August Sets New Global Heat Benchmark as U.S. Summer Breaks Records
August marked the warmest month on record worldwide; the United States also saw a summer of unprecedented heat with broad implications.
Carrier USS Abraham Lincoln Heads Home After Thailand Port Call and Middle East Deployment
USS Abraham Lincoln departed Sunday for the United States after a five-day Thailand port call and an extended Middle East deployment.
Sharp Drop in Overdose Deaths After Years of Rise, But Toll Remains High
After annual U.S. overdose deaths topped 105,000, 2024 saw a marked decline; preliminary 2025 figures and international drops signal change amid ongoing challenges.
Fery ready to learn from US Open debut as exit highlights priorities
Arthur Fery says he knows what to work on after his US Open debut ended in defeat and remains ready to test himself against top players.
FTC alleges hidden ad fees; Amazon shares fall amid scrutiny
FTC accuses Amazon of adding billions in hidden ad surcharges by inflating floor prices during peak shopping periods.
Locked Seats, Lingering Risks: How Verstappen and Norris Deals Reshape the F1 Driver Market
Extensions for Verstappen and Norris reduce high-profile F1 vacancies, but retirements, regulation shifts or team changes could still unsettle the market.
FDA approves Mimrylo (rusfertide) as a new option for polycythemia vera
FDA clears rusfertide (Mimrylo) by Protagonist and Takeda as a weekly injection to treat polycythemia vera.
- 1
- 2